Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioblastoma × Gabapentin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 6 Hot Flashes 4 Pain, Postoperative 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Pain 2 Mucositis 2 Vomiting 1 Urinary Bladder Neoplasms 1 Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Psychotic Disorders 1 Oropharyngeal Neoplasms 1 Neurotoxicity Syndromes 1 Neuralgia 1 Neoplasms 1 Nausea 1 Myalgia 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Laryngeal Diseases 1 Ileus 1 Glioblastoma 1 Epilepsy 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Depression 1 Constipation 1 Colonic Neoplasms 1

Interventions

Temozolomide 344 Radiotherapy 172 Bevacizumab 133 Radiation 66 Magnetic Resonance Spectroscopy 56 Lomustine 42 pembrolizumab 35 Irinotecan 35 Carmustine 35 Surgical Procedures, Operative 32 Nivolumab 26 Carboplatin 25 Radiosurgery 22 Specimen Handling 20 Erlotinib Hydrochloride 20 Chemotherapy, Adjuvant 20 Radiotherapy, Intensity-Modulated 18 Aminolevulinic Acid 18 Drug Therapy 17 Cyclophosphamide 16 sargramostim 15 O(6)-benzylguanine 13 Radiotherapy, Conformal 12 Granulocyte-Macrophage Colony-Stimulating Factor 12 Everolimus 12 Vorinostat 11 Sunitinib 11 Cilengitide 11 temsirolimus 10 poly ICLC 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡